SCHEMBL7387696

SCHEMBL7387696

[O]C1CCCN(Cc2ccccc2)C1

nearest known ligand 0.66

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 3/20 0.66
▸ CYP3A4 P08684 3/20 0.66
▸ ALDH1A1 P00352 2/20 0.66
▸ CYP1A2 P05177 2/20 0.66
▸ CYP2C19 P33261 1/20 0.66
▸ KDM4E B2RXH2 2/20 0.56
▸ HPGD P15428 1/20 0.56
▸ CYP2C9 P11712 2/20 0.53
▸ BCHE P06276 3/20 0.52
▸ MAOB P27338 1/20 0.52
▸ SIGMAR1 Q99720 1/20 0.52
▸ ACHE P22303 1/20 0.50
▸ BACE1 P56817 1/20 0.50
▸ CHRM3 P20309 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2538630 0.95 CYP2D6 (0.59) CYP2D6CYP3A4ALDH1A1CYP1A2CYP2C19
SCHEMBL5858096 0.91 ACHE (0.59) CYP2D6CYP3A4ALDH1A1CYP1A2CYP2C19
SCHEMBL10523377 0.81 KDM4E (0.61) KDM4ESIGMAR1
SCHEMBL4815665 0.81 CYP2D6 (0.68) CYP2D6CYP3A4ALDH1A1CYP1A2CYP2C19
SCHEMBL4257757 0.80 ACHE (0.69) ALDH1A1BCHESIGMAR1ACHEBACE1
SCHEMBL994346 0.79 CYP2D6 (0.66) CYP2D6CYP3A4ALDH1A1CYP1A2CYP2C19
SCHEMBL21419827 0.79 CYP2D6 (0.66) CYP2D6CYP3A4ALDH1A1CYP1A2CYP2C19
SCHEMBL22755862 0.79 CYP2D6 (0.66) CYP2D6CYP3A4ALDH1A1CYP1A2CYP2C19
SCHEMBL22829165 0.79 CYP2D6 (0.66) CYP2D6CYP3A4ALDH1A1CYP1A2CYP2C19
SCHEMBL3369987 0.79 CYP2D6 (0.66) CYP2D6CYP3A4ALDH1A1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5696268-A REACTING N-ACYLAMINO ACID DERIVATIVE WITH OPTICALLY ACTIVE ENAMINE DERIVATIVE, REACTING PRODUCT WITH AMMONIA OR AMMONIUM SALT FUJIREBIO INC. (JP) 1997-12-09 — — US claimed
US-5644059-A REACTION OF KETONE WITH ACRYLAMIDE AND AMMONIA OR AMMONIUM SALT FUJIREBIO INC. (JP) 1997-07-01 — — US claimed
EP-0488345-A1 1,4-Dihydropyridine derivatives and methods of producing the same FUJIREBIO INC. (JP) 1992-06-03 — — EP claimed
US-4886813-A INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1989-12-12 — — US claimed
CN-103896946-B For preventing and treating the noval chemical compound of various autoimmune disease 浙江导明医药科技有限公司 2018-04-03 — — CN disclosed
US-5859244-A EXHIBIT VASODILATING ACTIVITY BASED ON CALCIUM ANTAGONISM AND PLATELET-ACTIVATING FACTOR ANTAGONISM FUJIREBIO, INC. (JP) 1999-01-12 — — US disclosed
US-5763614-A VASODILATION BASED ON CALCIUM ANTAGONISM AND PAF ANTAGONISM FUJIREBIO INC. (JP) 1998-06-09 — — US disclosed
US-5696268-A REACTING N-ACYLAMINO ACID DERIVATIVE WITH OPTICALLY ACTIVE ENAMINE DERIVATIVE, REACTING PRODUCT WITH AMMONIA OR AMMONIUM SALT FUJIREBIO INC. (JP) 1997-12-09 — — US disclosed
US-5644059-A REACTION OF KETONE WITH ACRYLAMIDE AND AMMONIA OR AMMONIUM SALT FUJIREBIO INC. (JP) 1997-07-01 — — US disclosed
US-5367081-A Vasodilator, antiallergen FUJIREBIO INC. (JP) 1994-11-22 — — US disclosed
EP-0488345-A1 1,4-Dihydropyridine derivatives and methods of producing the same FUJIREBIO INC. (JP) 1992-06-03 — — EP disclosed
US-4886813-A INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1989-12-12 — — US disclosed
Send feedback